| __timestamp | Dr. Reddy's Laboratories Limited | GSK plc |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 8246000000 |
| Thursday, January 1, 2015 | 42585000000 | 9232000000 |
| Friday, January 1, 2016 | 45702000000 | 9366000000 |
| Sunday, January 1, 2017 | 46372000000 | 9672000000 |
| Monday, January 1, 2018 | 46910000000 | 9915000000 |
| Tuesday, January 1, 2019 | 48890000000 | 11402000000 |
| Wednesday, January 1, 2020 | 50129000000 | 11456000000 |
| Friday, January 1, 2021 | 54559000000 | 10975000000 |
| Saturday, January 1, 2022 | 62081000000 | 8372000000 |
| Sunday, January 1, 2023 | 105931000000 | 9385000000 |
| Monday, January 1, 2024 | 77201000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, understanding the financial strategies of industry leaders is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: GSK plc and Dr. Reddy's Laboratories Limited, from 2014 to 2023.
Dr. Reddy's Laboratories has shown a remarkable upward trend, with SG&A expenses surging by approximately 173% over the decade. This growth reflects their aggressive market expansion and investment in global operations. In contrast, GSK plc's expenses have remained relatively stable, with a modest increase of around 14% over the same period, indicating a more conservative approach.
Interestingly, 2023 marked a significant leap for Dr. Reddy's, with expenses peaking at over 100% compared to the previous year, while GSK's data for 2024 remains unavailable. This disparity highlights differing strategic priorities and market dynamics.
Bristol-Myers Squibb Company or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Zoetis Inc. vs Dr. Reddy's Laboratories Limited: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Dr. Reddy's Laboratories Limited
Breaking Down SG&A Expenses: GSK plc vs ADMA Biologics, Inc.
GSK plc vs Amicus Therapeutics, Inc.: SG&A Expense Trends
GSK plc and Merus N.V.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: GSK plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Merus N.V.
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Iovance Biotherapeutics, Inc.
Dr. Reddy's Laboratories Limited or Xencor, Inc.: Who Manages SG&A Costs Better?